TR199902103A2 - Iyonik kompleks içinde suda çözülebilen farmasötik bilesim ve bunun kullanimi. - Google Patents
Iyonik kompleks içinde suda çözülebilen farmasötik bilesim ve bunun kullanimi.Info
- Publication number
- TR199902103A2 TR199902103A2 TR1999/02103A TR9902103A TR199902103A2 TR 199902103 A2 TR199902103 A2 TR 199902103A2 TR 1999/02103 A TR1999/02103 A TR 1999/02103A TR 9902103 A TR9902103 A TR 9902103A TR 199902103 A2 TR199902103 A2 TR 199902103A2
- Authority
- TR
- Turkey
- Prior art keywords
- polypeptide
- ionic complex
- water
- pharmaceutical composition
- soluble pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Suda çözülebilen bir bilesim olup, kirpi proteinleri, morfojen kemik proteinleri, büyüme faktörleri, eritropoietin, trombopoietin, G-CSF, interlösinler ve interferonlar arasindan seçilmis farmasötik açidan etkili bir polipeptidin iyonik bir kompleksi ile bir amfifil bilesik içerir. Polipeptit ile amfifil bilesik iyonik bir kompleks olustururlar ve bu kompleks olusumu söz konusu polipeptidin çözünürlügünü arttirmaz fakat polipeptidin etkinligini ve/veya geciktirilmis salinimini arttirir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98116494 | 1998-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199902103A2 true TR199902103A2 (tr) | 2000-04-21 |
Family
ID=8232558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/02103A TR199902103A2 (tr) | 1998-09-01 | 1999-08-31 | Iyonik kompleks içinde suda çözülebilen farmasötik bilesim ve bunun kullanimi. |
Country Status (30)
Country | Link |
---|---|
US (3) | US6867182B2 (tr) |
EP (1) | EP1002547B1 (tr) |
JP (1) | JP3664373B2 (tr) |
KR (1) | KR100403075B1 (tr) |
CN (1) | CN1325118C (tr) |
AR (1) | AR023044A1 (tr) |
AT (1) | ATE318616T1 (tr) |
AU (1) | AU755930B2 (tr) |
BR (1) | BR9903984B1 (tr) |
CA (1) | CA2281049C (tr) |
CO (1) | CO5271726A1 (tr) |
DE (1) | DE69930033T2 (tr) |
ES (1) | ES2258830T3 (tr) |
GC (1) | GC0000107A (tr) |
HR (1) | HRP990272B1 (tr) |
HU (1) | HUP9902952A1 (tr) |
ID (1) | ID22964A (tr) |
IL (1) | IL131626A0 (tr) |
MA (1) | MA26682A1 (tr) |
MY (1) | MY127935A (tr) |
NO (1) | NO994214L (tr) |
NZ (1) | NZ337527A (tr) |
PE (1) | PE20001027A1 (tr) |
PL (1) | PL194218B1 (tr) |
RU (1) | RU2180855C2 (tr) |
SG (1) | SG85670A1 (tr) |
TR (1) | TR199902103A2 (tr) |
TW (1) | TW570805B (tr) |
YU (1) | YU42399A (tr) |
ZA (1) | ZA995601B (tr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060193825A1 (en) * | 2003-04-29 | 2006-08-31 | Praecis Phamaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US20050112087A1 (en) * | 2003-04-29 | 2005-05-26 | Musso Gary F. | Pharmaceutical formulations for sustained drug delivery |
JP4871720B2 (ja) * | 2003-06-10 | 2012-02-08 | エルジー ライフサイエンス リミテッド | 血清アルブミンを含まない、安定なヒトエリスロポエチン水溶液 |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
HUE038247T2 (hu) * | 2004-05-19 | 2018-10-29 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Nátrium-deoxikolátot tartalmazó injektálható készítmény |
EP1905433A1 (en) * | 2005-07-15 | 2008-04-02 | Transcu Ltd. | Percutaneous absorption patch with application position indicating function, and iontophoresis device |
JP2007037868A (ja) * | 2005-08-05 | 2007-02-15 | Transcutaneous Technologies Inc | 経皮投与装置及びその制御方法 |
US20070042041A1 (en) * | 2005-08-17 | 2007-02-22 | Board Of Trustees Of The University Of Arkansas | Drug-surfactant complexes for sustained release |
WO2007032423A1 (ja) * | 2005-09-16 | 2007-03-22 | Tti Ellebeau, Inc. | カテーテル型イオントフォレーシス装置 |
US20070093787A1 (en) * | 2005-09-30 | 2007-04-26 | Transcutaneous Technologies Inc. | Iontophoresis device to deliver multiple active agents to biological interfaces |
WO2007079116A1 (en) * | 2005-12-28 | 2007-07-12 | Tti Ellebeau, Inc. | Electroosmotic pump apparatus and method to deliver active agents to biological interfaces |
US7848801B2 (en) * | 2005-12-30 | 2010-12-07 | Tti Ellebeau, Inc. | Iontophoretic systems, devices, and methods of delivery of active agents to biological interface |
WO2007123707A1 (en) * | 2006-03-30 | 2007-11-01 | Tti Ellebeau, Inc. | Controlled release membrane and methods of use |
EP2034976A2 (en) * | 2006-07-05 | 2009-03-18 | Tti Ellebeau, Inc. | Delivery device having self-assembling dendritic polymers and method of use thereof |
JP5550338B2 (ja) | 2006-07-31 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | ペグ化持続型インスリン |
CN101541830A (zh) | 2006-09-22 | 2009-09-23 | 诺沃-诺迪斯克有限公司 | 蛋白酶抗性的胰岛素类似物 |
US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
FR2908414B1 (fr) | 2006-11-13 | 2012-01-20 | Centre Nat Rech Scient | Immobilisation de proteines membranaires sur un support par l'intermediaire d'une molecule amphiphile |
EP2123259A1 (en) * | 2007-01-16 | 2009-11-25 | Hokkaido University | Liposome preparation for iontophoresis having antioxidant component encapsulated therein |
ES2563038T3 (es) | 2007-04-30 | 2016-03-10 | Novo Nordisk A/S | Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca |
JP5675347B2 (ja) * | 2007-06-01 | 2015-02-25 | ノボ・ノルデイスク・エー/エス | 安定した非水性薬学的組成物 |
JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
ES2618073T3 (es) | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
EP2910571B1 (en) | 2008-03-18 | 2016-10-05 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
AU2009291764A1 (en) * | 2008-09-10 | 2010-03-18 | Transcu Ltd. | Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e.g., continuous web-based process |
WO2012134540A2 (en) * | 2010-10-22 | 2012-10-04 | Vanderbilt University | Injectable synthetic pur composite |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
RU2581020C2 (ru) * | 2009-12-22 | 2016-04-10 | Селлдекс Терапьютикс, Инк. | Композиции вакцин |
MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
CA2867903C (en) | 2012-03-23 | 2023-02-14 | Amicrobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
WO2015052088A1 (en) | 2013-10-07 | 2015-04-16 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
US20180236088A1 (en) * | 2015-11-04 | 2018-08-23 | Postech Academy- Industry Foundation | Composition for skin permeation comprising cationic molecular transporter and protein |
MX2019006463A (es) | 2016-12-16 | 2019-08-14 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina. |
CN110740744A (zh) | 2017-04-06 | 2020-01-31 | 艾麦克罗比公司 | 性能和安全性增强的局部施用的抗微生物剂的组合物和应用 |
US11198831B2 (en) | 2019-01-31 | 2021-12-14 | Kvi Llc | Lubricant for a device |
CN113660953A (zh) * | 2019-04-01 | 2021-11-16 | 豪夫迈·罗氏有限公司 | 用于稳定含蛋白质制剂的组合物和方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985004328A1 (en) * | 1984-03-28 | 1985-10-10 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
US4604377A (en) | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
LU85971A1 (fr) | 1985-06-25 | 1987-01-13 | Oreal | Nouveaux composes lipidiques amphiphiles, leur procede de preparation et leurs applications,notamnent en cosmetique et en dermopharmacie |
JPS62207226A (ja) | 1986-03-07 | 1987-09-11 | Sumitomo Pharmaceut Co Ltd | 経鼻投与用製剤 |
FR2615194B1 (fr) | 1987-05-11 | 1991-06-14 | Rhone Poulenc Chimie | Particules de polymere comportant, implantees a leur surface des molecules amphiphiles portant des groupes ionogenes ou reactifs, leur procede de preparation et leur application en biologie |
WO1989010758A1 (en) | 1988-05-02 | 1989-11-16 | Zynaxis Technologies, Inc. | Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
US5688761A (en) | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
FR2694559B1 (fr) | 1992-08-06 | 1994-10-28 | Atta | Nouveaux dérivés amphiphiles d'aminoacides ou de peptides, leur procédé de préparation et leur utilisation dans des préparations à usage biomédical. |
WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
JP3290745B2 (ja) | 1993-03-31 | 2002-06-10 | 藤平 正道 | 単分子膜のパターン形成方法 |
IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US5789543A (en) * | 1993-12-30 | 1998-08-04 | President And Fellows Of Harvard College | Vertebrate embryonic pattern-inducing proteins and uses related thereto |
CA2179029C (en) * | 1993-12-30 | 2009-02-24 | Philip W. Ingham | Vertebrate embryonic pattern-inducing hedgehog-like proteins |
US20030186357A1 (en) * | 1993-12-30 | 2003-10-02 | Philip W. Ingham | Vertebrate embryonic pattern-inducing proteins, and uses related thereto |
FR2714621B1 (fr) | 1994-01-06 | 1996-02-23 | Centre Nat Rech Scient | Procédé de préparation de liposomes sans utilisation de solvant organique. |
GB9417524D0 (en) | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
US5653987A (en) * | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
US5750123A (en) * | 1996-06-28 | 1998-05-12 | Chesebrough-Pond's Co., Division Of Conopco, Inc. | Vitamin C delivery system |
IL129295A0 (en) * | 1996-10-07 | 2000-02-17 | Univ Johns Hopkins Med | Novel hedgehog-derived polypeptides |
AU713591B2 (en) | 1996-10-15 | 1999-12-09 | Seikagaku Corporation | Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide |
WO1998020298A1 (en) * | 1996-11-08 | 1998-05-14 | Northern Magnetics, Inc. | Sensing and controlling the location of elements of a linear motor |
US5759811A (en) * | 1996-11-13 | 1998-06-02 | The Regents Of The University Of California | Mutant human hedgehog gene |
JPH10194987A (ja) * | 1997-01-14 | 1998-07-28 | Youtai Iwamoto | 骨・軟骨形成用組成物 |
JPH114695A (ja) * | 1997-04-25 | 1999-01-12 | Hayashibara Biochem Lab Inc | ヘッジホッグ蛋白質 |
US6639051B2 (en) * | 1997-10-20 | 2003-10-28 | Curis, Inc. | Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
ES2179414T3 (es) | 1997-11-22 | 2003-01-16 | Roche Diagnostics Gmbh | Procedimiento mejorado de estabilizacion de proteinas. |
EP0919618A1 (de) | 1997-11-28 | 1999-06-02 | Boehringer Mannheim Gmbh | Aktive Hedgehog-Protein-Mutante, Verfahren zur Herstellung und Verwendung |
MXPA00005494A (es) | 1997-12-03 | 2003-05-19 | Curis Inc | Composiciones de proteina hidrofobicamente modificada y metodos. |
JP3648051B2 (ja) * | 1998-02-02 | 2005-05-18 | 富士通株式会社 | 関連情報検索装置及びプログラム記録媒体 |
EP0947201B1 (en) * | 1998-02-04 | 2006-06-28 | Curis, Inc. | Pharmaceutical composition of hedgehog proteins and use thereof |
CA2260423C (en) | 1998-02-04 | 2006-06-20 | Kurt Lang | Pharmaceutical composition of hedgehog proteins and use thereof |
ATE308563T1 (de) * | 1998-04-30 | 2005-11-15 | Curis Inc | Aktives hedgehog-protein-konjugat, verfahren zur herstellung und verwendung |
US20050021440A1 (en) * | 2003-04-04 | 2005-01-27 | Scott Dresden | Integrated dynamic pricing and procurement support for e-commerce advertising channels |
US20070203906A1 (en) * | 2003-09-22 | 2007-08-30 | Cone Julian M | Enhanced Search Engine |
US20050114319A1 (en) * | 2003-11-21 | 2005-05-26 | Microsoft Corporation | System and method for checking a content site for efficacy |
US10515374B2 (en) * | 2005-03-10 | 2019-12-24 | Adobe Inc. | Keyword generation method and apparatus |
-
1999
- 1999-08-18 TW TW088114073A patent/TW570805B/zh not_active IP Right Cessation
- 1999-08-24 EP EP99116537A patent/EP1002547B1/en not_active Expired - Lifetime
- 1999-08-24 ES ES99116537T patent/ES2258830T3/es not_active Expired - Lifetime
- 1999-08-24 DE DE69930033T patent/DE69930033T2/de not_active Expired - Lifetime
- 1999-08-24 AT AT99116537T patent/ATE318616T1/de active
- 1999-08-27 NZ NZ337527A patent/NZ337527A/xx unknown
- 1999-08-27 MY MYPI99003715A patent/MY127935A/en unknown
- 1999-08-27 CO CO99054477A patent/CO5271726A1/es not_active Application Discontinuation
- 1999-08-27 IL IL13162699A patent/IL131626A0/xx unknown
- 1999-08-27 SG SG9904209A patent/SG85670A1/en unknown
- 1999-08-27 ID IDP990812D patent/ID22964A/id unknown
- 1999-08-27 CN CNB991192451A patent/CN1325118C/zh not_active Expired - Fee Related
- 1999-08-28 KR KR10-1999-0036053A patent/KR100403075B1/ko not_active IP Right Cessation
- 1999-08-30 YU YU42399A patent/YU42399A/sh unknown
- 1999-08-30 GC GCP1999255 patent/GC0000107A/xx active
- 1999-08-30 CA CA2281049A patent/CA2281049C/en not_active Expired - Fee Related
- 1999-08-30 AR ARP990104345A patent/AR023044A1/es not_active Application Discontinuation
- 1999-08-31 HR HR990272A patent/HRP990272B1/xx not_active IP Right Cessation
- 1999-08-31 PE PE1999000871A patent/PE20001027A1/es not_active Application Discontinuation
- 1999-08-31 RU RU99118890/14A patent/RU2180855C2/ru active
- 1999-08-31 AU AU44866/99A patent/AU755930B2/en not_active Ceased
- 1999-08-31 TR TR1999/02103A patent/TR199902103A2/tr unknown
- 1999-08-31 NO NO994214A patent/NO994214L/no not_active Application Discontinuation
- 1999-08-31 ZA ZA9905601A patent/ZA995601B/xx unknown
- 1999-08-31 MA MA25748A patent/MA26682A1/fr unknown
- 1999-09-01 HU HU9902952A patent/HUP9902952A1/hu unknown
- 1999-09-01 BR BRPI9903984-2A patent/BR9903984B1/pt not_active IP Right Cessation
- 1999-09-01 PL PL335203A patent/PL194218B1/pl unknown
- 1999-09-01 JP JP24801399A patent/JP3664373B2/ja not_active Expired - Lifetime
-
2001
- 2001-09-17 US US09/953,721 patent/US6867182B2/en not_active Expired - Lifetime
-
2005
- 2005-01-10 US US11/032,492 patent/US20050123610A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/931,118 patent/US8519098B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199902103A2 (tr) | Iyonik kompleks içinde suda çözülebilen farmasötik bilesim ve bunun kullanimi. | |
TR199701071T2 (tr) | Aktif madde ulastirmaya mahsus bilesikler ve terkipler. | |
ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
BR0002548A (pt) | CÈncavo para uma unidade de processamento de safra. | |
HRP20010463B1 (en) | Controlled release galantamine composition | |
IT8026950A0 (it) | Particelle di sostanze solubili in lipoidi e composizioni biologicamente attive che le contengono. | |
DE69911993D1 (de) | Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen | |
BR0007787A (pt) | Composição de amido, uso de uma composição de amido processo para preparar um alimento espesso, alimento, e, confeito | |
ATE212351T1 (de) | Androsten-derivate | |
WO1999045098A3 (en) | Delivery or proteins into eukaryotic cells with recombinant yersinia | |
PT967987E (pt) | Composicoes para o tratamento de tumores contendo extractos de cartilagem de tubarao e agentes antineoplasicos | |
ATE260675T1 (de) | Methoden zur behandlung der salzabhängigen hypertonie | |
ATE252375T1 (de) | Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung | |
DE69940980D1 (de) | Rana pipiens proteine und deren verwendung in der behandlung von tumoren | |
BR0209619A (pt) | Uso de derivados de ciclosporina de posição 3 para crescimento capilar | |
DE60003943D1 (de) | Trimegestone enthaltende pharmazeutische zusammensetzungen | |
TR200200566T2 (tr) | Pestisidler olarak tetrahidropiridinler | |
TR200002269T2 (tr) | Katı yakıt katkıları. | |
BR0208961A (pt) | Composição farmacêutica demonstrando atividade anti-tumor, método para fabricar a mesma, e uso de uma tolueno sulfonamida | |
TR199901987T2 (tr) | Suda çözünmezligi yüksek bir etken madde ihtiva eden sulu farmakolojik bilesim. | |
ATE263555T1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
DK1189615T3 (da) | Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner | |
DK1056755T3 (da) | Fungicider | |
DE69900466D1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen | |
HRP20020071B1 (en) | Pharmaceutical composition and preparation thereof |